Paper38057783
Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients.
Liao W and 12 others. Cardiovasc Diabetol, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients. Papers, record 38057783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38057783
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ST Elevation Myocardial Infarction | Major topic |
| Percutaneous Coronary Intervention | Major topic |
| Hyperglycemia | Major topic |
| Humans | |
| Glycated Hemoglobin | |
| Blood Glucose | |
| Hospital Mortality | |
| Treatment Outcome | |
| Biomarkers | |
| Prognosis | |
| Risk Factors | |
| Albumins |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32788282 | Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32788282 | PubMed |
| 2 | 15728645 | Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. | Eur Heart J | 2005 | https://conductscience.org/library/papers/15728645 | PubMed |
| 3 | 36944934 | Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/36944934 | PubMed |
| 4 | 20103758 | Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. | JAMA | 2010 | https://conductscience.org/library/papers/20103758 | PubMed |
| 5 | 30165437 | 2018 ESC/EACTS Guidelines on myocardial revascularization. | Eur Heart J | 2019 | https://conductscience.org/library/papers/30165437 | PubMed |
| 6 | 11990931 | Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. | Crit Care Med | 2002 | https://conductscience.org/library/papers/11990931 | PubMed |
| 7 | 18316629 | Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. | Blood | 2008 | https://conductscience.org/library/papers/18316629 | PubMed |
| 8 | 21359582 | Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study. | Diabetologia | 2011 | https://conductscience.org/library/papers/21359582 | PubMed |
| 9 | 35739511 | Short and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/35739511 | PubMed |
| 10 | 19349317 | High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. | Circulation | 2009 | https://conductscience.org/library/papers/19349317 | PubMed |
| 11 | 34996365 | Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients. | BMC Cardiovasc Disord | 2022 | https://conductscience.org/library/papers/34996365 | PubMed |
| 12 | 22271188 | The emerging role of HDL in glucose metabolism. | Nat Rev Endocrinol | 2012 | https://conductscience.org/library/papers/22271188 | PubMed |
| 13 | 11238470 | Clinical review 124: Diabetic dyslipidemia: causes and consequences. | J Clin Endocrinol Metab | 2001 | https://conductscience.org/library/papers/11238470 | PubMed |
| 14 | 30496103 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. | Lancet | 2018 | https://conductscience.org/library/papers/30496103 | PubMed |
| 15 | 11044416 | TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. | Circulation | 2000 | https://conductscience.org/library/papers/11044416 | PubMed |
| 16 | 38206306 | The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes. | Eur Heart J | 2024 | https://conductscience.org/library/papers/38206306 | PubMed |
| 17 | 35351149 | Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/35351149 | PubMed |
| 18 | 21804130 | Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. | Circulation | 2011 | https://conductscience.org/library/papers/21804130 | PubMed |
| 19 | 36470546 | Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/36470546 | PubMed |
| 20 | 36647062 | Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/36647062 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983516 | Stress-hyperglycemia ratio, frailty index, and their product in relation to incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis of CHARLS. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42983516 | PubMed |
| 42674805 | Prognostic significance of stress hyperglycemia ratio in patients undergoing percutaneous coronary intervention: a dose-response meta-analysis. | BMJ Open Diabetes Res Care | 2026 | https://conductscience.org/library/papers/42674805 | PubMed |
| 42609313 | Association between stress hyperglycemia ratio and acute total occlusion in patients with non-ST-segment elevation myocardial infarction. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42609313 | PubMed |
| 42536673 | The prognostic significance of stress hyperglycemic ratio in critically Ill patients with hypertension: A study using the MIMIC-IV database. | PLoS One | 2026 | https://conductscience.org/library/papers/42536673 | PubMed |
| 41688977 | Stress hyperglycemia ratio in coronary artery disease: a systematic review and meta-analysis of severity and prognosis. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41688977 | PubMed |
| 41645081 | Stress hyperglycemia ratio is associated with microcirculatory resistance in patients with ST-segment elevation myocardial infarction. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/41645081 | PubMed |
| 41495766 | From metabolism to myocardium: the missing link of admission dysglycemia in early cardiac recovery. | Cardiovasc Diabetol Endocrinol Rep | 2026 | https://conductscience.org/library/papers/41495766 | PubMed |
| 41315443 | Stress hyperglycemia ratio and albumin predict in-hospital outcomes in patients with acute myocardial infarction: a cohort study. | Sci Rep | 2025 | https://conductscience.org/library/papers/41315443 | PubMed |
| 41076534 | Impact of glucometabolic status on type 4a myocardial infarction in patients with non-ST-segment elevation myocardial infarction: the role of stress hyperglycemia ratio. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/41076534 | PubMed |
| 40725663 | The Stress Hyperglycemia Ratio as a Predictor of Clinical Outcomes in Acute Pancreatitis: A Retrospective Cohort Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40725663 | PubMed |
| 39920777 | Assessment of stress hyperglycemia ratio to predict all-cause mortality in patients with critical cerebrovascular disease: a retrospective cohort study from the MIMIC-IV database. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/39920777 | PubMed |
| 39741358 | Effects of stress hyperglycemia ratio upon long-lasting prognosis in coronary artery disease patients with or lacking chronic renal impairment: findings from a Chinese multi-center observational study. | Diabetol Metab Syndr | 2024 | https://conductscience.org/library/papers/39741358 | PubMed |
| 39502569 | Association of stress hyperglycemia ratio with presence and severity of chronic kidney disease among US adults with diabetes mellitus. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39502569 | PubMed |
| 38929812 | Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention. | J Pers Med | 2024 | https://conductscience.org/library/papers/38929812 | PubMed |
| 38468331 | The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38468331 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38057783
GET https://conductscience.org/api/papers/v1/38057783/references?page=2